Viemed Healthcare Inc (VMD.CA) Stock Fundamental Analysis
Canada - Toronto Stock Exchange - TSX:VMD - CA92663R1055 - Common Stock
10.45 CAD
+0.29 (+2.85%)
VMD gets a fundamental rating of 7 out of 10. The analysis compared the fundamentals against 14 industry peers in the Health Care Providers & Services industry. VMD gets an excellent profitability rating and is at the same time showing great financial health properties. VMD is not overvalued while it is showing excellent growth. This is an interesting combination. This makes VMD very considerable for growth and quality investing!
1. Profitability
1.1 Basic Checks
In the past year VMD was profitable.
In the past year VMD had a positive cash flow from operations.
Each year in the past 5 years VMD has been profitable.
In the past 5 years VMD always reported a positive cash flow from operatings.
1.2 Ratios
VMD has a better Return On Assets (6.16%) than 95.24% of its industry peers.
VMD's Return On Equity of 8.47% is fine compared to the rest of the industry. VMD outperforms 76.19% of its industry peers.
Looking at the Return On Invested Capital, with a value of 7.90%, VMD belongs to the top of the industry, outperforming 90.48% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for VMD is above the industry average of 7.27%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 6.16% | ||
| ROE | 8.47% | ||
| ROIC | 7.9% |
ROA(3y)13.66%
ROA(5y)13.79%
ROE(3y)18.18%
ROE(5y)20.63%
ROIC(3y)11.36%
ROIC(5y)13.33%
1.3 Margins
VMD has a better Profit Margin (5.42%) than 90.48% of its industry peers.
VMD's Profit Margin has declined in the last couple of years.
VMD has a Operating Margin of 7.73%. This is amongst the best in the industry. VMD outperforms 90.48% of its industry peers.
VMD's Operating Margin has declined in the last couple of years.
VMD's Gross Margin of 61.00% is amongst the best of the industry. VMD outperforms 90.48% of its industry peers.
In the last couple of years the Gross Margin of VMD has declined.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 7.73% | ||
| PM (TTM) | 5.42% | ||
| GM | 61% |
OM growth 3Y-18.23%
OM growth 5Y-20.06%
PM growth 3Y-24.99%
PM growth 5Y-23.88%
GM growth 3Y-4.35%
GM growth 5Y-3.72%
2. Health
2.1 Basic Checks
VMD has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
Compared to 1 year ago, VMD has less shares outstanding
The debt/assets ratio for VMD has been reduced compared to a year ago.
2.2 Solvency
An Altman-Z score of 6.66 indicates that VMD is not in any danger for bankruptcy at the moment.
The Altman-Z score of VMD (6.66) is better than 90.48% of its industry peers.
The Debt to FCF ratio of VMD is 0.65, which is an excellent value as it means it would take VMD, only 0.65 years of fcf income to pay off all of its debts.
VMD's Debt to FCF ratio of 0.65 is amongst the best of the industry. VMD outperforms 100.00% of its industry peers.
VMD has a Debt/Equity ratio of 0.08. This is a healthy value indicating a solid balance between debt and equity.
The Debt to Equity ratio of VMD (0.08) is better than 95.24% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.08 | ||
| Debt/FCF | 0.65 | ||
| Altman-Z | 6.66 |
ROIC/WACC0.94
WACC8.43%
2.3 Liquidity
A Current Ratio of 1.14 indicates that VMD should not have too much problems paying its short term obligations.
VMD has a Current ratio (1.14) which is comparable to the rest of the industry.
A Quick Ratio of 0.99 indicates that VMD may have some problems paying its short term obligations.
Looking at the Quick ratio, with a value of 0.99, VMD is in line with its industry, outperforming 52.38% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.14 | ||
| Quick Ratio | 0.99 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 21.05% over the past year.
VMD shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -6.17% yearly.
Looking at the last year, VMD shows a very strong growth in Revenue. The Revenue has grown by 27.38%.
Measured over the past years, VMD shows a very strong growth in Revenue. The Revenue has been growing by 24.23% on average per year.
EPS 1Y (TTM)21.05%
EPS 3Y-13.28%
EPS 5Y-6.17%
EPS Q2Q%133.33%
Revenue 1Y (TTM)27.38%
Revenue growth 3Y20.01%
Revenue growth 5Y24.23%
Sales Q2Q%38.14%
3.2 Future
The Earnings Per Share is expected to grow by 54.71% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 21.44% on average over the next years. This is a very strong growth
EPS Next Y75.07%
EPS Next 2Y65.14%
EPS Next 3Y54.71%
EPS Next 5YN/A
Revenue Next Year31.41%
Revenue Next 2Y25.78%
Revenue Next 3Y21.44%
Revenue Next 5YN/A
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
4. Valuation
4.1 Price/Earnings Ratio
VMD is valuated quite expensively with a Price/Earnings ratio of 34.83.
Based on the Price/Earnings ratio, VMD is valued cheaply inside the industry as 80.95% of the companies are valued more expensively.
When comparing the Price/Earnings ratio of VMD to the average of the S&P500 Index (26.57), we can say VMD is valued slightly more expensively.
Based on the Price/Forward Earnings ratio of 19.28, the valuation of VMD can be described as rather expensive.
85.71% of the companies in the same industry are more expensive than VMD, based on the Price/Forward Earnings ratio.
VMD is valuated at similar levels of the S&P average when we compare the Price/Forward Earnings ratio to 24.04, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 34.83 | ||
| Fwd PE | 19.28 |
4.2 Price Multiples
VMD's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. VMD is cheaper than 76.19% of the companies in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of VMD is on the same level as its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 19.11 | ||
| EV/EBITDA | 9.09 |
4.3 Compensation for Growth
The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
The decent profitability rating of VMD may justify a higher PE ratio.
A more expensive valuation may be justified as VMD's earnings are expected to grow with 54.71% in the coming years.
PEG (NY)0.46
PEG (5Y)N/A
EPS Next 2Y65.14%
EPS Next 3Y54.71%
5. Dividend
5.1 Amount
VMD does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
TSX:VMD (12/21/2023, 7:00:00 PM)
10.45
+0.29 (+2.85%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners31.13%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap402.32M
Revenue(TTM)169.78M
Net Income(TTM)9.21M
Analysts80
Price Target19.25 (84.21%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)0.17%
Min EPS beat(2)-18.46%
Max EPS beat(2)18.81%
EPS beat(4)2
Avg EPS beat(4)8.43%
Min EPS beat(4)-18.46%
Max EPS beat(4)48.51%
EPS beat(8)3
Avg EPS beat(8)-0.69%
EPS beat(12)5
Avg EPS beat(12)22.7%
EPS beat(16)7
Avg EPS beat(16)24.4%
Revenue beat(2)1
Avg Revenue beat(2)1.01%
Min Revenue beat(2)-1.19%
Max Revenue beat(2)3.2%
Revenue beat(4)2
Avg Revenue beat(4)0.6%
Min Revenue beat(4)-1.49%
Max Revenue beat(4)3.2%
Revenue beat(8)6
Avg Revenue beat(8)1.73%
Revenue beat(12)8
Avg Revenue beat(12)1.84%
Revenue beat(16)10
Avg Revenue beat(16)-1.12%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-18.18%
EPS NY rev (1m)-5.45%
EPS NY rev (3m)-5.45%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)96920.2%
Revenue NY rev (1m)-1.27%
Revenue NY rev (3m)-1.27%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 34.83 | ||
| Fwd PE | 19.28 | ||
| P/S | 1.79 | ||
| P/FCF | 19.11 | ||
| P/OCF | 7.66 | ||
| P/B | 2.79 | ||
| P/tB | 3.87 | ||
| EV/EBITDA | 9.09 |
EPS(TTM)0.3
EY2.87%
EPS(NY)0.54
Fwd EY5.19%
FCF(TTM)0.55
FCFY5.23%
OCF(TTM)1.36
OCFY13.05%
SpS5.84
BVpS3.74
TBVpS2.7
PEG (NY)0.46
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 6.16% | ||
| ROE | 8.47% | ||
| ROCE | 11.15% | ||
| ROIC | 7.9% | ||
| ROICexc | 8.64% | ||
| ROICexgc | 12.03% | ||
| OM | 7.73% | ||
| PM (TTM) | 5.42% | ||
| GM | 61% | ||
| FCFM | 9.36% |
ROA(3y)13.66%
ROA(5y)13.79%
ROE(3y)18.18%
ROE(5y)20.63%
ROIC(3y)11.36%
ROIC(5y)13.33%
ROICexc(3y)16.33%
ROICexc(5y)18.87%
ROICexgc(3y)16.33%
ROICexgc(5y)18.87%
ROCE(3y)16.03%
ROCE(5y)18.81%
ROICexgc growth 3Y-20.42%
ROICexgc growth 5Y-25.33%
ROICexc growth 3Y-20.42%
ROICexc growth 5Y-25.33%
OM growth 3Y-18.23%
OM growth 5Y-20.06%
PM growth 3Y-24.99%
PM growth 5Y-23.88%
GM growth 3Y-4.35%
GM growth 5Y-3.72%
F-Score4
Asset Turnover1.14
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.08 | ||
| Debt/FCF | 0.65 | ||
| Debt/EBITDA | 0.25 | ||
| Cap/Depr | 116.84% | ||
| Cap/Sales | 13.98% | ||
| Interest Coverage | 24.31 | ||
| Cash Conversion | 118.48% | ||
| Profit Quality | 172.53% | ||
| Current Ratio | 1.14 | ||
| Quick Ratio | 0.99 | ||
| Altman-Z | 6.66 |
F-Score4
WACC8.43%
ROIC/WACC0.94
Cap/Depr(3y)152.39%
Cap/Depr(5y)165.61%
Cap/Sales(3y)14.43%
Cap/Sales(5y)13.89%
Profit Quality(3y)59.5%
Profit Quality(5y)83.35%
High Growth Momentum
Growth
EPS 1Y (TTM)21.05%
EPS 3Y-13.28%
EPS 5Y-6.17%
EPS Q2Q%133.33%
EPS Next Y75.07%
EPS Next 2Y65.14%
EPS Next 3Y54.71%
EPS Next 5YN/A
Revenue 1Y (TTM)27.38%
Revenue growth 3Y20.01%
Revenue growth 5Y24.23%
Sales Q2Q%38.14%
Revenue Next Year31.41%
Revenue Next 2Y25.78%
Revenue Next 3Y21.44%
Revenue Next 5YN/A
EBIT growth 1Y35.22%
EBIT growth 3Y-1.87%
EBIT growth 5Y-0.68%
EBIT Next Year275.8%
EBIT Next 3Y76.08%
EBIT Next 5YN/A
FCF growth 1Y829.24%
FCF growth 3Y-5.24%
FCF growth 5Y-9.57%
OCF growth 1Y101.83%
OCF growth 3Y13.28%
OCF growth 5Y18.21%
Viemed Healthcare Inc / VMD.CA FAQ
What is the ChartMill fundamental rating of Viemed Healthcare Inc (VMD.CA) stock?
ChartMill assigns a fundamental rating of 7 / 10 to VMD.CA.
What is the valuation status for VMD stock?
ChartMill assigns a valuation rating of 5 / 10 to Viemed Healthcare Inc (VMD.CA). This can be considered as Fairly Valued.
Can you provide the profitability details for Viemed Healthcare Inc?
Viemed Healthcare Inc (VMD.CA) has a profitability rating of 7 / 10.
What is the earnings growth outlook for Viemed Healthcare Inc?
The Earnings per Share (EPS) of Viemed Healthcare Inc (VMD.CA) is expected to grow by 75.07% in the next year.